Glenmark Pharma Q2 Results : Co posts Rs 355 crore net profit on robust sales (...)
Glenmark Pharma reported Rs 340 crore net profit in Q2FY25 led by robust sales growth in India and Europe. The drugmaker reported a net loss of Rs 180 crore in the corresponding quarter of the previous year.
Site référencé: The Economic Times
The Economic Times
10 midcap companies show consistent decline in debt-to-equity ratio
18/08/2025
GST reform push : Emkay raises Nifty target to 28,000 for September 2026, picks its 5 top beneficiary stocks
18/08/2025
Why FIIs selling Indian stocks is not wrong : Helios Capital's Samir Arora explains
18/08/2025
Are defence and aerospace stocks set to soar ? Matt Orton’s view on global market tailwinds
18/08/2025
Can Mark Zuckerberg duck deposition in Meta privacy class action ?
18/08/2025
10+ MFs added these 11 stocks in July 2025. Do you own any ?
18/08/2025
